Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-03

Clinical Trial Update: The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the effectiveness and safety of rExenatide-4 for Type 2 diabetes mellitus in Chinese patients; current status is not disclos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • rExenatide-4

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Type2 Diabetes Mellitus | Phase 3 | Status: UNKNOWN